|
|
 |
|
Viewing report
|
|
|
|
European Asthma and Rhinitis Therapeutic Product Markets
Frost & Sullivan, Nov 1998
As the incidence of asthma and allergic rhinitis rises, the market for products to treat these diseases are expected to show strong growth. This Frost & Sullivan report analyzes the markets for a full range of product to treat asthma and rhinitis, including anti-inflammatory agents, mast cell mediators, inhaled bronchodilators, methylxanthines and antihistamines. It examines factors driving and restraining growth in eight European regional markets, providing a detailed road map of the industry's future.
Customers who bought this item also bought
Commercial and Pipeline Insight: Allergic Rhinitis
The Asthma, COPD & Allergic Rhinitis Market Outlook to 2011
U.S. Asthma Therapeutics Market
Pipeline Insight: Asthma/COPD/Allergic Rhinitis - As Patents Expire, Novel Combinations Inspire
European Asthma Therapeutics Markets
Asthma Therapeutics - Global Strategic Business Report
Market Dynamics 2000: Allergic Rhinitis: Effects of Major Patent Expiries On An Expanding Market
Pipeline Insight: Asthma, Copd and Allergic Rhinitis - The Needs of Severe Patients Must be Addressed
Pipeline Insight: Asthma, COPD and Allergic Rhinitis - Weak Late Stage Pipeline Leaves Innovation to Phase I/II Candidates
U.S. Asthma Therapies Markets
Strategic Perspectives: Allergic Rhinitis - Impact of a blockbuster going bust
Asthma & COPD Therapeutics
|
|
|
|
